These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 7492086)
1. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Bucklin SE; Lake P; Lögdberg L; Morrison DC Antimicrob Agents Chemother; 1995 Jul; 39(7):1462-6. PubMed ID: 7492086 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of lipopolysaccharide-induced TNF-alpha production by semisynthetic polymyxin-B conjugated dextran. Coyne CP; Moritz JT; Fenwick BW Biotechnol Ther; 1994-1995; 5(3-4):137-62. PubMed ID: 8608324 [TBL] [Abstract][Full Text] [Related]
3. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532 [TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic evaluation of the neutralization of endotoxin by PMX622 in mice. Lake P; DeLeo J; Cerasoli F; Logdberg L; Weetall M; Handley D Antimicrob Agents Chemother; 2004 Aug; 48(8):2987-92. PubMed ID: 15273110 [TBL] [Abstract][Full Text] [Related]
5. Effects of polymyxin B and Salmonella typhimurium antiserum on horses given endotoxin intravenously. Durando MM; MacKay RJ; Linda S; Skelley LA Am J Vet Res; 1994 Jul; 55(7):921-7. PubMed ID: 7978630 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock. Hwang YH; Park BK; Lim JH; Kim MS; Park SC; Hwang MH; Yun HI Eur J Pharmacol; 2007 Feb; 556(1-3):166-71. PubMed ID: 17126323 [TBL] [Abstract][Full Text] [Related]
7. Covalent polymyxin B conjugate with human immunoglobulin G as an antiendotoxin reagent. Drabick JJ; Bhattacharjee AK; Hoover DL; Siber GE; Morales VE; Young LD; Brown SL; Cross AS Antimicrob Agents Chemother; 1998 Mar; 42(3):583-8. PubMed ID: 9517936 [TBL] [Abstract][Full Text] [Related]
8. Reduction of endotoxin-induced vascular permeability by monoclonal antibodies against lipopolysaccharide determinants. Rubin RM; Noland J; Rosenbaum JT Circ Shock; 1992 Mar; 36(3):217-23. PubMed ID: 1377103 [TBL] [Abstract][Full Text] [Related]
9. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Cirioni O; Giacometti A; Ghiselli R; Bergnach C; Orlando F; Silvestri C; Mocchegiani F; Licci A; Skerlavaj B; Rocchi M; Saba V; Zanetti M; Scalise G Antimicrob Agents Chemother; 2006 May; 50(5):1672-9. PubMed ID: 16641434 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. Ghiselli R; Giacometti A; Cirioni O; Orlando F; Mocchegiani F; Pacci AM; Scalise G; Saba V J Surg Res; 2001 Oct; 100(2):183-8. PubMed ID: 11592790 [TBL] [Abstract][Full Text] [Related]
11. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. Bucklin SE; Morrison DC J Infect Dis; 1995 Dec; 172(6):1519-27. PubMed ID: 7594711 [TBL] [Abstract][Full Text] [Related]
12. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant. Sil D; Shrestha A; Kimbrell MR; Nguyen TB; Adisechan AK; Balakrishna R; Abbo BG; Malladi S; Miller KA; Short S; Cromer JR; Arora S; Datta A; David SA Antimicrob Agents Chemother; 2007 Aug; 51(8):2811-9. PubMed ID: 17548488 [TBL] [Abstract][Full Text] [Related]
13. Anti-endotoxin Properties of Polymyxin B-immobilized Fibers. Tani T; Shimizu T; Tani M; Shoji H; Endo Y Adv Exp Med Biol; 2019; 1145():321-341. PubMed ID: 31364085 [TBL] [Abstract][Full Text] [Related]
14. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs. From AH; Fong JS; Good RA Infect Immun; 1979 Mar; 23(3):660-4. PubMed ID: 222676 [TBL] [Abstract][Full Text] [Related]
15. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Masubuchi Y; Horie T Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297 [TBL] [Abstract][Full Text] [Related]
17. Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Zhang GH; Mann DM; Tsai CM Infect Immun; 1999 Mar; 67(3):1353-8. PubMed ID: 10024582 [TBL] [Abstract][Full Text] [Related]
18. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. MacKay RJ; Clark CK; Logdberg L; Lake P Am J Vet Res; 1999 Jan; 60(1):68-75. PubMed ID: 9918150 [TBL] [Abstract][Full Text] [Related]
19. Biological characterization of endotoxins released from antibiotic-treated Pseudomonas aeruginosa and Escherichia coli. Kirikae T; Kirikae F; Saito S; Tominaga K; Tamura H; Uemura Y; Yokochi T; Nakano M Antimicrob Agents Chemother; 1998 May; 42(5):1015-21. PubMed ID: 9593119 [TBL] [Abstract][Full Text] [Related]
20. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor. Weiss CA; Wasiluk KR; Kellogg TA; Dunn DL Surgery; 2000 Aug; 128(2):339-44. PubMed ID: 10923014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]